Two Sigma Securities’s ResMed RMD Stock Holding History

Two Sigma Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,500	Closed	-$610K	–	2934
2024 Q3	$610K	Sell	2,500 -2,000	-44%	-$447K	0.01%	1171
2024 Q2	$861K	Buy	+4,500	New	+$913K	0.01%	1166
2024 Q1	–	Sell	-1,800	Closed	-$310K	–	3539
2023 Q4	$310K	Sell	1,800 -2,600	-59%	-$399K	﹤0.01%	1973
2023 Q3	$651K	Buy	+4,400	New	+$796K	0.01%	1324
2023 Q1	–	Sell	-1,300	Closed	-$271K	–	3166
2022 Q4	$271K	Hold	1,300	–	–	0.01%	1628
2022 Q3	$284K	Buy	+1,300	New	+$296K	0.01%	1629
2020 Q4	–	Sell	-1,900	Closed	-$326K	–	1903
2020 Q3	$326K	Sell	1,900 -9,000	-83%	-$1.66M	0.01%	811
2020 Q2	$2.09M	Buy	+10,900	New	+$1.78M	0.05%	218
2018 Q4	–	Sell	-6,700	Closed	-$773K	–	2728
2018 Q3	$773K	Sell	6,700 -800	-11%	-$87.6K	0.01%	1153
2018 Q2	$777K	Buy	7,500 +4,400	+142%	+$445K	﹤0.01%	1503
2018 Q1	$305K	Buy	+3,100	New	+$293K	﹤0.01%	1996

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Two Sigma Securities's RMD Position: Q2 2025 in Review

Two Sigma Securities sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,372 shares — an estimated $307K sold.

Two Sigma Securities first reported a position in RMD in Q2 2018 and held it in 15 quarters. The position peaked at $703K in Q4 2022. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Two Sigma Securities reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 1,372 ResMed shares in Q2 2025, an estimated $307K.
Two Sigma Securities first reported a position in ResMed in Q2 2018 and held it in 15 quarters.
Two Sigma Securities's ResMed position peaked at $703K in Q4 2022.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.